Seragon Pharmaceuticals Investor Relations Salaries in San Diego | Comparably
Seragon Pharmaceuticals develops small-molecule drugs for the treatment of estrogen receptor dependent breast cancer. read more
EMPLOYEE
PARTICIPANTS
4
TOTAL
RATINGS
106

Seragon Pharmaceuticals Investor Relations Salaries in San Diego

The average Seragon Pharmaceuticals Investor Relations in San Diego earns an estimated $57,335 annually. Seragon Pharmaceuticals' Investor Relations compensation is $24,595 less than the US average for a Investor Relations.

In San Diego, The Communications Department at Seragon Pharmaceuticals earns $9,929 more on average than the Enterprise Risk Department.

Last updated 5 years ago.

$35k
$47k
$63k
$70k
$109k
$139k
$168k
$57,335
Average Compensation
$57,335
avg. base

Investor Relations Salaries at Seragon Pharmaceuticals

* estimated salary

Compensation at Seragon Pharmaceuticals by Department

In San Diego, The Communications Department averages $9,929 more than the Enterprise Risk Department.

Communications
$195,641 Avg. total comp.
Enterprise Risk
$185,712 Avg. total comp.
-$10k
Product
$151,052 Avg. total comp.
-$45k

Investor Relations Compensation by Gender (All Companies)

The average female Investor Relations at companies similar size to Seragon Pharmaceuticals reported making $155,000, while the average male Investor Relations at similar sized companies reported making $50,000.

How Investor Relations at Seragon Pharmaceuticals Rate Their Compensation

The majority of Investor Relations at Seragon Pharmaceuticals believe they're compensated fairly. 50% of Investor Relations at Seragon Pharmaceuticals say they receive annual bonuses, and the majority (67%) are satisfied with their benefits. See more compensation ratings at Seragon Pharmaceuticals

×
Rate your company